|
DGCR11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.048600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.993600E-01 |
| Normal-vs-Stage2 |
6.465800E-01 |
| Normal-vs-Stage3 |
7.759400E-01 |
| Normal-vs-Stage4 |
4.238800E-01 |
| Stage1-vs-Stage2 |
8.985800E-01 |
| Stage1-vs-Stage3 |
5.378200E-01 |
| Stage1-vs-Stage4 |
9.133600E-01 |
| Stage2-vs-Stage3 |
7.954000E-01 |
| Stage2-vs-Stage4 |
8.538400E-01 |
| Stage3-vs-Stage4 |
5.893400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.142400E-01 |
| Normal-vs-AfricanAmerican |
4.785900E-02 |
| Normal-vs-Asian |
1.734150E-01 |
| Caucasian-vs-AfricanAmerican |
4.556400E-02 |
| Caucasian-vs-Asian |
3.088000E-01 |
| AfricanAmerican-vs-Asian |
8.436600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.305000E-01 |
| Normal-vs-Female |
9.188500E-04 |
| Male-vs-Female |
3.29060000359149E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.181200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.260800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.984600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.342600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.682000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.016200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.451200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.708200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.587800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.463600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.164800E-01 |
| Normal-vs-Grade 2 |
3.372400E-01 |
| Normal-vs-Grade 3 |
6.267200E-01 |
| Normal-vs-Grade 4 |
9.881000E-01 |
| Grade 1-vs-Grade 2 |
1.911840E-01 |
| Grade 1-vs-Grade 3 |
1.582620E-01 |
| Grade 1-vs-Grade 4 |
1.294840E-01 |
| Grade 2-vs-Grade 3 |
5.186000E-01 |
| Grade 2-vs-Grade 4 |
3.407600E-01 |
| Grade 3-vs-Grade 4 |
6.622800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.238650E-01 |
| Normal-vs-ccB subtype |
9.991800E-01 |
| ccA subtype-vs-ccB subtype |
7.859600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.670000E-02 |
| Normal-vs-N1 |
8.721500E-02 |
| N0-vs-N1 |
1.174780E-01 |
|
|
